This med called Adagrasib is mainly for folks with NSCLC and a certain kind of KRAS G12C mutation. The way it works is by stopping that altered KRAS protein. It’s a big deal in how lung cancer like NSCLC grows and gets worse.
The tablets come in a strength of 200 mg each and the recommended dose is 600 mg twice daily, which can be taken with or without food. Each bottle has 180 tabs, which should cover you for a 30-day run if you’re taking the suggested dose. You’ll be using it as part of your overall cancer treatment plan, which might include some other stuff too.
